Equities Analysts Issue Forecasts for Balchem Q2 Earnings

Balchem Co. (NASDAQ:BCPC - Free Report) - Stock analysts at Sidoti Csr dropped their Q2 2025 EPS estimates for shares of Balchem in a research note issued on Monday, April 28th. Sidoti Csr analyst D. Harriman now forecasts that the basic materials company will post earnings per share of $1.25 for the quarter, down from their prior estimate of $1.28. The consensus estimate for Balchem's current full-year earnings is $4.64 per share. Sidoti Csr also issued estimates for Balchem's Q1 2026 earnings at $1.32 EPS.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The business had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm's revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.03 EPS.

A number of other analysts have also recently weighed in on the company. HC Wainwright set a $180.00 price objective on Balchem and gave the stock a "buy" rating in a research report on Monday. StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, Sidoti raised Balchem to a "hold" rating in a report on Tuesday, February 25th.

Balchem Stock Down 0.1 %

Balchem stock opened at $156.01 on Wednesday. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The stock has a 50 day moving average of $163.83 and a two-hundred day moving average of $166.94. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $5.08 billion, a price-to-earnings ratio of 39.70, a PEG ratio of 4.41 and a beta of 0.75.

Institutional Investors Weigh In On Balchem

A number of large investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. grew its stake in Balchem by 2.6% in the 1st quarter. Principal Financial Group Inc. now owns 169,226 shares of the basic materials company's stock valued at $28,092,000 after acquiring an additional 4,311 shares during the last quarter. Teacher Retirement System of Texas grew its stake in Balchem by 11.8% in the 1st quarter. Teacher Retirement System of Texas now owns 34,896 shares of the basic materials company's stock valued at $5,793,000 after acquiring an additional 3,695 shares during the last quarter. KBC Group NV grew its stake in Balchem by 24.1% in the 1st quarter. KBC Group NV now owns 1,582 shares of the basic materials company's stock valued at $263,000 after acquiring an additional 307 shares during the last quarter. Yorktown Management & Research Co Inc acquired a new stake in Balchem in the 1st quarter valued at about $241,000. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Balchem by 243.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,390 shares of the basic materials company's stock valued at $1,559,000 after purchasing an additional 6,654 shares in the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.